These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38823177)

  • 1. SLC25A19 is a novel prognostic biomarker related to immune invasion and ferroptosis in HCC.
    Liu S; Zhang P; Wu Y; Zhou H; Wu H; Jin Y; Wu D; Wu G
    Int Immunopharmacol; 2024 Jul; 136():112367. PubMed ID: 38823177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma.
    Li C; Zhang ED; Ye Y; Xiao Z; Huang H; Zeng Z
    Sci Rep; 2024 Jun; 14(1):14051. PubMed ID: 38890507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer.
    Dong Z; Dai B; Wu R; Fang K; Sui C; Geng L; Yang J
    Cancer Rep (Hoboken); 2024 Sep; 7(9):e2161. PubMed ID: 39307915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma.
    Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J
    Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC.
    Wang W; Wang L; Song C; Mu T; Hu J; Feng H
    J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
    Huang H; Lan C; Wei Y; Nong J; Liao X; Ye X; Deng G; Peng T; Zhou X
    Aging (Albany NY); 2024 Mar; 16(7):6229-6261. PubMed ID: 38552222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
    Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
    Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel ferroptosis phenotype-related clinical-molecular prognostic signature for hepatocellular carcinoma.
    Deng T; Hu B; Jin C; Tong Y; Zhao J; Shi Z; Zhang T; Deng L; Sun Z; Chen G; Wang Y
    J Cell Mol Med; 2021 Jul; 25(14):6618-6633. PubMed ID: 34085405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
    Tao S; Cui D; Cheng H; Liu X; Jiang Z; Chen H; Gao Y
    BMC Cancer; 2024 Feb; 24(1):194. PubMed ID: 38347489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identify an innovative ferroptosis-related gene in hepatocellular carcinoma.
    Hu G; Huang X; Zhang B; Gao P; Wu W; Wang J
    J Clin Lab Anal; 2022 Sep; 36(9):e24632. PubMed ID: 35908779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a prognostic model for hepatocellular carcinoma based on MED19 and clinical stage and determining MED19 as a therapeutic target.
    Jin X; Zhang Y; Hu W; Liu C; Cai D; Sun J; Wei Q; Cai Q
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):446. PubMed ID: 39369139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
    Yang X; Mei M; Yang J; Guo J; Du F; Liu S
    Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.